Search results
Results From The WOW.Com Content Network
Mayo Clinic Florida is a comprehensive medical center belonging to the Mayo Clinic in Jacksonville, ... Neurology & Neurosurgery #24 71.5 Orthopedics #29 65.2
John Harnett Noseworthy (born 9 November 1951) is an American neurologist who served as the president and chief executive officer of Mayo Clinic from 2009 to 2018. A board-certified neurologist specializing in multiple sclerosis, Noseworthy is the former editor-in-chief of Neurology, the official journal of the American Academy of Neurology. [1]
Alfredo Quiñones-Hinojosa (also known as "Dr. Q") is a Mexican-American neurosurgeon, author, and researcher. Currently, he is the William J. and Charles H. Mayo Professor and Chair of Neurologic Surgery and runs a basic science research lab at the Mayo Clinic Jacksonville in Florida. He is an editorial board member and reviewer for several ...
Jones and his team developed new criteria to help physicians in diagnosing LANS that include the following core clinical factors: presents with a slow, predominant neurodegenerative condition with ...
Michael S. Okun (born July 5, 1971) is an American neurologist, neuroscientist and author. He is the co-founder and director of the Norman Fixel Institute for Neurological Diseases at University of Florida Health [2] and is also the chair of the Department of Neurology at the University of Florida and the Medical Director/Advisor for the Parkinson's Foundation. [2]
Discount pricing starts at $24.99 a month at Spectrum. Verizon. Discount pricing starts at $20 a month at Verizon. AT&T. Discount pricing starts at $30 a month at AT&T. See 2 more. Yet finding an ...
A drug used in the prevention of migraine may also help reduce so-called rebound headaches, according to a new review of data from a randomized, double-blind, placebo-controlled migraine trial.
In 2002, Mayo Clinic researchers identified a humoral mechanism, targeting a perivascular protein, as the culprit of NMO, [26] and in 2004 an unknown specific autoantibody was found. [79] In 2005 they identified the aquaporin 4 protein as the target of the disease, and developed the first in-house test to aid in the diagnosis of NMO by ...